MoonLake Immunotherapeutics

MLTXStocksPharmaceuticals MajorSwitzerlandNasdaqUSD

Price

$10.83

Today

+2.3%

YTD

-17.7%

About

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company that is driven by scientific discovery and a commitment to patient care. The company specialises in delivering immunotherapies to treat a broad range of diseases, and operates in diverse geographical locales. MoonLake Immunotherapeutics operates in the biopharmaceutical industry, aiming to use its targeted therapeutics to combat severe immune disorders. Its operations encompass research, development and the manufacturing of cutting-edge medicines. Keep up to date on the latest share price changes by adding MLTX stock to your eToro watchlist.

Price chart

Closing price history for MLTX (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-2.97

P/S (TTM)0.00

P/B (TTM)2.22

Market cap$968.51M

Cap tierSmall-cap

Industry avg P/E-7.42

Profitability

Gross marginUnknown

EBIT margin0.00%

Net marginUnknown

ROE-67.44%

ROA-51.00%

Earnings & Revenue

Revenue (TTM)$0.00

Revenue growth (1Y)Unknown

EPS (TTM)-$3.84

Free cash flow$-225.18M

Total debt$101.53M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.70

Employees130

Next earnings5 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.